Monitoring of human immunodeficiency virus infection in resource-constrained countries

Clinical Infectious Diseases

Volumn 37, Issue SUPPL. 1, 2003, Pages

  Crowe, Suzanne ^a,b,c   Turnbull, Shannon ^a   Oelrichs, Robert ^a   Dunne, Amanda ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; CELL ASSAY; COMPUTER ANALYSIS; COST CONTROL; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DIP STICK TEST; DNA MICROARRAY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LYMPHOCYTE COUNT; PRIORITY JOURNAL; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; HEALTH RESOURCES; HIV INFECTIONS; HIV-1; HUMANS; QUALITY CONTROL; VIRAL LOAD;

EID: 0038300741     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375369     Document Type: Review

References (53)

1. Kassa E, Rinke de Wit TF, Hailu E, et al. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 1999; 13:381-9.
2. Morgan D, Mahe C, Mayanja B, Whitworth JA. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ 2002; 324:193-6.
3. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:80-5.
4. Adewuyi JO, Courts AM, Latif AS, Smith H, Abayomi AE, Moyo AA. Haematologic features of the human immunodeficiency virus (HIV) infection in adult Zimbabweans. Cent Afr J Med 1999; 45:26-30.
5. Montaner JS, Le TN, Le N, Craib KJ, Schechter MT. Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS 1992; 6:719-24.
6. World Health Organization. Acquired immune deficiency syndrome (AIDS): interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990; 65:221-8.
7. Schechter MS, Le N, Craib KJP, Le TN, O'Shaughnessy MV, Montaner JSG. Use of the Markov model to estimate the waiting times in a modified WHO staging system for HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:474-9.
8. Schechter M, Zajdenverg R, Machado LL, Pinto ME, Lima LA, Perez MA. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J Acquir Immune Defic Syndr 1994; 7:163-8.
9. Wiktor SZ, Sassan-Morokro M, Grant AD, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 1999; 353:1469-75.
10. Badri M, Ehrlich R, Wood R, Maartens G. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS 2001; 15:1143-8.
11. Crowe SM, Carlin JB, Stewart KI, Lucas R, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991; 4:770-6.
12. Vithayasai V, Sirisanthana T, Sakonwasun C, Suvanpiyasiri C. Flow cytometric analysis of T-lymphocytes subsets in adult Thais. Asian Pac J Allergy Immunol 1997; 15:141-6.
13. + T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:361-7.
14. + percentage in a group of HIV-1-infected South African patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:238-44.
15. Post FA, Wood R, Maartens G. CD4 and total lymphocyte counts as predictors of HIV disease progression. QJM 1996; 89:505-8.
16. + percentage in HIV-infected persons. JAMA 1993; 269:622-8.
17. Beck EJ, Kupek EJ, Gompels MM, Pinching AJ. Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect. Int J STD AIDS 1996; 7:422-8.
18. + cell count in monitoring response to antiretroviral therapy. Niger Postgrad Med J 2001; 8:105-11.
19. + T-cell counts on "single-platform" flow cytometers I. Primary CD4 gating. Br J Haematol 2000; 111:1198-208.
20. + T-cells in the peripheral blood of HIV-infected patients: an interlaboratory study of the FACSCount system. Cytometry 1999; 38:231-7.
21. World Health Organization Global Programme on AIDS. Report of a WHO workshop on flow cytometry and alternative methodologies for CD4 lymphocyte determinations: applications for developing countries. AIDS 1994; 8:1-4.
22. + lymphocyte counts. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:522-30.
23. + T lymphocyte determination. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:31-4.
24. + T-cell quantitation for use in developing countries. AIDS 1993; 7:1565-8.
25. + T lymphocytes in whole blood. J Acquir Immune Defic Syndr 1994; 7:1224-7.
26. + lymphocyte counts in human immunodeficiency virus - infected individuals. Clin Diagn Lab Immunol 1995; 2:623-5.
27. + T lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr 2001; 26:193-5.
28. Lyamuya EF, Kagoma C, Mbena EC, et al. Evaluation of the FACScount, TRAx CD4, and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods 1996; 195:103-12.
29. + peripheral T lymphocytes. Clin Chem 1999; 45:92-7.
30. + T lymphocyte counts in Africans. Trop Med Int Health 1999; 4:79-84.
31. Saah AJ, Spruill C, Hoover DR, et al. Helper T-lymphocyte count. TRAx CD4 test kit versus conventional flow cytometry. Arch Pathol Lab Med 1997; 121:960-2.
32. + lymphocyte counts determined by enzyme immunoassay (TRAx CD4 test kit) and flow cytometry. Clin Diagn Lab Immunol 1996; 3:371-3.
33. + lymphocyte counts. The National Heart, Lung and Blood Institute Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:522-30.
34. Paxton H, Pins M, Denton G, McGonigle D, Meisner PS, Phair JP. Comparison of CD4 cell count by a simple enzyme linked immunosorbent assay using the TRAx CD4 test kit and by flow cytometry and hematology. Clin Diagn Lab Immunol 1995; 2:104-14.
35. Pacifici R, Zuccaro P, Cozzi L, et al. Quantification of the variation due to lysing technique in immunophenotyping of healthy and HIV-infected individuals. Clin Biochem 1998; 31:165-72.
36. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients, total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 1990; 3:144-51.
37. + T lymphocyte counts of patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 21:1121-5.
38. Campbell PJ, Aurelius S, Blowes G, Harvey D. Decrease in CD4 lymphocyte counts with rest: implications for the monitoring of HIV infection. Int J STD AIDS 1997; 8:423-6.
39. Dunne AL, Crowe SM. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS 1997; 11:126-7.
40. Triques K, Coste J, Perret JL, et al. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol 1999; 37:110-6.
41. Alaeus A, Lidman K, Sonnerborg A, Albert J. Subtype specific problems with quantification of plasma HIV-1 RNA. AIDS 1997; 11:859-65.
42. Debyser Z, Van Wijngaerden E, Van Laethem K, et al. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res Hum Retroviruses 1998; 14:453-9.
43. Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999; 15:133-42.
44. Malmsten A, Ekstrand DHL, Akerblom L, et al. A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity. J Virol Methods 1998; 75:9-20.
45. Schupbach J, Flepp M, Pontelli D, Tomasik Z, Luthy R, Boni J. Heat mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS 1996; 10:1085-90.
46. Schupback J, Boni J, Flepp M, Tomasik Z, Joller H, Opravil M. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. J Med Virol 2001; 65:225-32.
47. Ortigao-de Sampaio MB, Abreu TF, Linhares-de-Carvalho MI, Ponce de Leon A, Castello Branco LR. Surrogate markers of disease progression in HIV-infected children in Rio de Janeiro, Brazil. J Trop Pediatr 1999; 45:299-302.
48. Ashton LJ, Carr A, Cunningham PH, et al. Predictors of progression in long-term non progressors. Australian Long Term Non Progressor Study Group. AIDS Res Hum Retroviruses 1998; 14:117-21.
49. Messele T, Brouwer M, Girma M, et al. Plasma levels of viro-immunological markers in HIV-infected and non infected Ethiopians: correlation with cell surface activation markers. Clin Immunol 2001; 98:212-9.
50. 2-microglobulin levels in HIV-1 positive and negative Tanzanian patients with tuberculosis. Int J STD AIDS 1995; 6:278-83.
51. Nkengasong JN, Kestens L, Ghys PD, et al. Human immunodeficiency virus type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Cote d'Ivoire. J Infect Dis 2001; 183:1405-8.
52. N'Gam PT, Jaffar S, Ricard D, et al. Immune stimulation by syphilis and malaria in HIV-2-infected and uninfected villagers in West Africa. Br J Biomed Sci 1997; 54:251-5.
53. + T cell counts by flow cytometry. II. The use of fixed whole blood in resource poor settings. J Immunol Methods 2001; 257:145-54.